Ingrezza 40 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJF4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,496
Award facts
- Contract value 100% obligated
- $15,496.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,496.24 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 21, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a broad range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Ingrezza, a neurological treatment medication, exemplifies the company's role in supporting Defense Health Agency requirements and broader military healthcare operations through competitively awarded, firm fixed-price transactions under the DLA's pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26FJF4Q?
SPE2DR26FJF4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FJF4Q worth?
The government has obligated $15,496 on SPE2DR26FJF4Q.
Is contract SPE2DR26FJF4Q an order under another contract?
Yes. SPE2DR26FJF4Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF4Q competed?
The extent of competition for SPE2DR26FJF4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award